Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by ledrogon Aug 15, 2018 1:57pm
132 Views
Post# 28466410

RE:RE:RE:RE:RE:RE:Feeling depressed maybe? Look at this chart:

RE:RE:RE:RE:RE:RE:Feeling depressed maybe? Look at this chart:

I think short covering, especially after the news about cancelling the proposed share offering...that it (to me obviously) had a big impact on RVX moving from around $1.30 to as high as $3.77 in the wake of the US listing/Rothschild news.  Short interest was over 1.6 million as recently as June 15th.

Up to July 31st it had been cut about in half from that 1.6 million....down to ~840K

But that doesn't include the trading that's taken place since they announced that they're going to be seekign a US listing with Rothschild and Co as advisors, that news came out after the closing bell on July 31st and the 7th DSMB news which saw RVX jump as high as $3.77

I think its possible that there was an increase in short selling to satisfy buyers jumping in on those news stories....

Bullboard Posts